资讯
A 51-year-old man with limb-girdle muscular dystrophy died after receiving Sarepta's experimental gene therapy and experiencing acute liver failure.
The firm will combine every 15 shares into one share in order to comply with Nasdaq's minimum bid price requirement.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果